Cytosorbents
$8.999876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$8.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.09 (+1.01%) Today
$0.00 (0.00%) As of 9:14 PM UTC after-hours
Why Robinhood?
You can buy or sell Cytosorbents and other stocks, options, and ETFs commission-free!
About CTSO
CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.
CEO
Phillip P. Chan
Employees
195
Headquarters
Monmouth Junction, New Jersey
Founded
2002
Market Cap
383.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
198.61K
High Today
$9.01
Low Today
$8.80
Open Price
$9.00
Volume
114.01K
52 Week High
$11.74
52 Week Low
$7.13
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
CTSO Earnings
-$0.22
-$0.15
-$0.07
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 4, After Hours